Achaogen Public
Achaogen, a biopharmaceutical company, discovers and develops broad-spectrum antibiotics to treat multi-drug resistant bacterial infections.
Industry:
PharmTech
Technology:
Cancer
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Headquarters:
South San Francisco, California, United States
Employee Number:
1-10
Founded Date:
2004